Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2003
09/04/2003US20030165816 Comprises mutant hepatitis B surface antigen for detecting viral diseases; immunoassays; kidney disorders
09/04/2003US20030165814 Screening for sensitivity to mystery swine disease virus infection by transfecting cells with CD antigens; animal husbandry
09/04/2003US20030165813 Using membrane composition to determine the ability of a compound or mixture of compounds to permeate lipid membrane associated with nervous system tissue
09/04/2003US20030165810 Measuring visoelasticity of mucus from patients suffering from cystic fibrosis, pneumonia or bronchitis and evaluating effectiveness of deoxyribonuclease, antibiotic and respiratory disease treatments in improving lung function
09/04/2003US20030165809 MARKs as modifiers of the p53 pathway and methods of use
09/04/2003US20030165808 Identifying culture medium components using total charge, molecular weight, isoelectric point, total dipole moment, isotropic surface area, electronic charge index and hydrophobicity
09/04/2003US20030165807 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
09/04/2003US20030165806 Comprises transport protein with four transmenbrane domains for modulating heart activity; drug screening
09/04/2003US20030165540 Sentinel virus II
09/04/2003US20030165538 Vaccines, biocatalyst; supplying to respiratory system, mucous membrane; modulate immunology response; fusion protein with spore overcoatings
09/04/2003US20030165511 Protein-virus Complex; culture product; viricides
09/04/2003US20030165509 Compositions and methods for homoconjugates of antibodies which induce growth arrest or apoptosis of tumor cells
09/04/2003US20030165506 Novel alpha-catenin expressed in heart and testis
09/04/2003US20030165501 Protein antagonist; insulin resistance; muscle disorders
09/04/2003US20030165497 RRP sequences and knockout mice and uses thereof
09/04/2003US20030165494 Rheumatic diseases; anticholesterol agents; cardiovascular disorders; multiple sclerosis
09/04/2003US20030165491 Anticancer agents; controlling cell differentiation; complexing; insertion plasmids; genetic engineering
09/04/2003US20030165490 22196, a novel human aminopeptidase
09/04/2003US20030165481 Amyloid peptide inactivating enzyme to treat Alzheimer's disease
09/04/2003US20030165479 Generating antibodies; modulation polypeptide; adjusting gene expression
09/04/2003US20030165465 Treatment of neoplasms with viruses
09/04/2003US20030165459 Binding to tumor necrosis factor
09/04/2003US20030165458 Anticholesterol agents; anticholesterol agents; immunology diseases; autoimmune diseases
09/04/2003US20030165430 Transgenic fatty acid transport one (FATP1) non-human knockout mammals uses thereof
09/04/2003US20030165429 Method for measuring skin absorbability of a substance
09/04/2003US20030165406 Container for urine accumulation; liquid impervious backing; contactor wick; selaing strips; drug screening
09/04/2003US20030165405 Assaying device and method for in field urinalysis
09/04/2003US20030165263 Histological assessment
09/04/2003US20030164698 Electromagnetic analysis of concrete tensioning wires
09/04/2003US20030164456 Apparatus and method for detecting fecal and ingesta contamination on hands using an lllumination imaging device
09/04/2003US20030164451 Measuring infrared spectrum of a lubricant, locating frequency range of absorbency for carbonate species within infrared spectrum, determining value of absorbance for peak of interest within band frequency; calculating Total Base Number
09/04/2003US20030164312 To detect gas in the parts per billion concentration range; response time
09/04/2003US20030164310 Method and appratus for improved gas detection
09/04/2003US20030164253 Fluid drilling system
09/04/2003US20030164136 Wetness indicator having improved colorant retention
09/04/2003US20030164051 Method and device for sampling and storing urine specimen
09/04/2003US20030164024 Biosensor and method for production thereof
09/04/2003US20030164023 Method for operating a sensor element
09/04/2003DE20309883U1 Electrical conductivity sensor, for plasticized rubber containing carbon black, comprising concentric electrodes insulated by high pressure sealing rings
09/04/2003DE20121901U1 Analysis of gaseous constituent of samples, e.g. carbon dioxide for TOC determination in water, involves transferring the gas from a sample receiver via an adapter to an analysis vessel fitted with a pressure equalizer
09/04/2003CA2743750A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from respiratory syncytial virus
09/04/2003CA2517027A1 Minicell compositions and methods
09/04/2003CA2478475A1 Method for drying water-borne materials
09/04/2003CA2477726A1 Use of tyrosine kinase inhibitors for treating substance use disorders
09/04/2003CA2477569A1 Selective binding of pathological forms of prion proteins using polyionic polymers
09/04/2003CA2477503A1 Surface modification, linker attachment, and polymerization methods
09/04/2003CA2477459A1 Comparative field analysis (comfa) utilizing topomeric alignment of molecular fragments
09/04/2003CA2477417A1 Methods and products based on oligomerization of stress proteins
09/04/2003CA2477309A1 Screening process
09/04/2003CA2477271A1 Nanostructures containing pilin protein
09/04/2003CA2477270A1 Nanostructures containing antibody assembly units
09/04/2003CA2477253A1 Compositions and method for regulation of calcium-dependent signalling in brain
09/04/2003CA2477249A1 Novel type-1 cytokine receptor glm-r
09/04/2003CA2477239A1 Drug signatures
09/04/2003CA2477235A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
09/04/2003CA2477234A1 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
09/04/2003CA2477225A1 Novel compositions and methods for cancer
09/04/2003CA2477171A1 Nanostructures containing pna joining or functional elements
09/04/2003CA2477035A1 Protein biomarkers that distinguish prostate cancer from non-malignant cells
09/04/2003CA2477033A1 Method for the analysis of lubricant basicity
09/04/2003CA2477008A1 Substituted pyrimidinones and pyrimidinthiones
09/04/2003CA2476890A1 Subtilisin carlsberg proteins with reduced immunogenicity
09/04/2003CA2476846A1 Method for detection of leptin receptor ligands
09/04/2003CA2476790A1 Population based assessments and means to rank the relative immunogenicity of proteins
09/04/2003CA2476765A1 Methods of preventing or treating brain ischemia or brain injury
09/04/2003CA2476518A1 Compositions and methods for the treatment of immune related diseases
09/04/2003CA2476480A1 Methods of making hypermutable cells using pmsr homologs
09/04/2003CA2475039A1 Macromolecular conjugates and processes for preparing same
09/04/2003CA2474700A1 Molecular diagnosis and prognosis of carcinomas
09/04/2003CA2467836A1 Interfacial biomaterials
09/04/2003CA2459155A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
09/04/2003CA2457907A1 Stain-directed molecular analysis for cancer prognosis and diagnosis
09/04/2003CA2451982A1 Method and nucleic acids for the analysis of colorectal cell proliferative disorders
09/04/2003CA2451045A1 Mycobacterial proteins as early antigens for serodiagnosis and vaccines
09/03/2003EP1340981A2 Antibodies for detecting amphetamine derivatives
09/03/2003EP1340980A1 Derivatives of amphetamine, antibodies against said derivatives, reagent kits, methods of producing said antibodies, and methods of detecting said derivatives
09/03/2003EP1340979A2 Neuropeptide receptor and uses thereof
09/03/2003EP1340978A1 Method of determining solution concentration and method of examining urine
09/03/2003EP1340977A2 Screening method for making and characterising polyurethane foams
09/03/2003EP1340976A1 Oil quality measurement apparatus
09/03/2003EP1340821A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
09/03/2003EP1340820A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
09/03/2003EP1340818A1 Method and nucleic acids for the analysis of a colon cell proliferative disorder
09/03/2003EP1340816A2 Quantitation of individual protein kinase activity
09/03/2003EP1340815A2 Determination of alpha-N-acetylgalactosaminidase activity
09/03/2003EP1340811A2 Antibodies with specificity for multiple adhesion molecules
09/03/2003EP1340810A1 Apparatus for treating sample in microamount
09/03/2003EP1340809A1 Well unit for detecting cell chemotaxis and separating chemotactic cells
09/03/2003EP1340769A1 CD4-gamma2 and CD4-IgG2 chimeras
09/03/2003EP1340764A2 Nucleic acid mediated electron transfer
09/03/2003EP1340544A1 Biochip including carbon nanotubes and method for sample separation using the same
09/03/2003EP1340507A1 Use of fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing
09/03/2003EP1340089A1 Computerized identification of normal and abnormal diurnal cortisol secretion patterns and levels of testosterone from human saliva samples
09/03/2003EP1340088A2 In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
09/03/2003EP1340087A2 Use of intramolecularly, covalently cross-linked proteins as binding partners in immunoassays
09/03/2003EP1340086A1 Assay for directly detecting a rs virus related biological cell in a body fluid sample
09/03/2003EP1340085A1 Assay for directly detecting a biological cell in a body fluid sample
09/03/2003EP1340084A2 Proteins, genes and their use for diagnosis and treatment of chronic asthma
09/03/2003EP1340083A1 Signal enhancement system with multiple labelled-moieties
09/03/2003EP1340082A2 Microfluidic device and method with transport of magnetic particles into and out of wells